Regulatory And Staffing Challenges For Private Hospitals In Southeast Asia - Private Healthcare World Asia 2011
This article was originally published in PharmAsia News
Executive Summary
SINGAPORE - Investor interest in Asia's private hospital infrastructure remains strong but regulatory limitation and lack of professional staff stymies its huge potential, industry experts told a Singapore conference June 15
You may also be interested in...
Trade Sale Or IPO for Australia’s Healthscope?
Investors looking to benefit from growth in the health care provision sector are circling as major Australian hospital operator Healthscope considers a relisting or potential trade sale.
Pfizer Escapes Anti-Monopoly Ruling In Indonesia For Amlodipine
An Indonesian court reversed a year-old anti-monopoly ruling against Pfizer Inc. and four of its units, the first cartel case in the country involving the pharmaceutical industry
Pfizer Escapes Anti-Monopoly Ruling In Indonesia For Amlodipine
An Indonesian court reversed a year-old anti-monopoly ruling against Pfizer Inc. and four of its units, the first cartel case in the country involving the pharmaceutical industry